The groundbreaking approach of this peptide represents a exciting advance in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide981622.dbblog.net/15359241/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment